BioVaxys Technology Corp.

Research BioVaxys Technology Corp. (5LB0) on Bullrun: market cap EUR 1.18M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker5LB0
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 1.18M
• Financial periodQ2 2025
• Net income-EUR 1.32M
• Free cash flow-EUR 1.06M

Valuation Snapshot

latest market cap is EUR 1.18M.

About BioVaxys Technology Corp.

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics. The company offers DPX immune educating technology platform and HapTenix neoantigen tumor cell construct platform for treating cancers, infectious diseases, antigen desensitization, and other immune diseases.

Frequently asked questions

What is BioVaxys Technology Corp.'s market cap?

BioVaxys Technology Corp.'s market capitalization is EUR 1.18M.

What does BioVaxys Technology Corp. do?

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.